186 related articles for article (PubMed ID: 15759036)
21. Interaction of rat renal glucocorticoid receptor with Hsp90 and Hsp70 upon stress provoked by mercury.
Brkljacić J; Perisić T; Dundjerski J; Matić G
J Appl Toxicol; 2007; 27(1):43-50. PubMed ID: 17177174
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models.
Banerji U; Walton M; Raynaud F; Grimshaw R; Kelland L; Valenti M; Judson I; Workman P
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7023-32. PubMed ID: 16203796
[TBL] [Abstract][Full Text] [Related]
23. Effect of geldanamycin on the kinetics of chaperone-mediated renaturation of firefly luciferase in rabbit reticulocyte lysate.
Thulasiraman V; Matts RL
Biochemistry; 1996 Oct; 35(41):13443-50. PubMed ID: 8873613
[TBL] [Abstract][Full Text] [Related]
24. Heat shock proteins and acute leukemias.
Thomas X; Campos L; Le QH; Guyotat D
Hematology; 2005 Jun; 10(3):225-35. PubMed ID: 16019471
[TBL] [Abstract][Full Text] [Related]
25. Cancer: the rules of attraction.
Neckers L; Lee YS
Nature; 2003 Sep; 425(6956):357-9. PubMed ID: 14508471
[No Abstract] [Full Text] [Related]
26. The cochaperone SGTA (small glutamine-rich tetratricopeptide repeat-containing protein alpha) demonstrates regulatory specificity for the androgen, glucocorticoid, and progesterone receptors.
Paul A; Garcia YA; Zierer B; Patwardhan C; Gutierrez O; Hildenbrand Z; Harris DC; Balsiger HA; Sivils JC; Johnson JL; Buchner J; Chadli A; Cox MB
J Biol Chem; 2014 May; 289(22):15297-308. PubMed ID: 24753260
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
28. Mechanistic studies on Hsp90 inhibition by ansamycin derivatives.
Onuoha SC; Mukund SR; Coulstock ET; Sengerovà B; Shaw J; McLaughlin SH; Jackson SE
J Mol Biol; 2007 Sep; 372(2):287-97. PubMed ID: 17662999
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90.
Xu W; Mimnaugh E; Rosser MF; Nicchitta C; Marcu M; Yarden Y; Neckers L
J Biol Chem; 2001 Feb; 276(5):3702-8. PubMed ID: 11071886
[TBL] [Abstract][Full Text] [Related]
30. The Hsp70-Hsp90 Chaperone Cascade in Protein Folding.
Morán Luengo T; Mayer MP; Rüdiger SGD
Trends Cell Biol; 2019 Feb; 29(2):164-177. PubMed ID: 30502916
[TBL] [Abstract][Full Text] [Related]
31. Nucleotide binding states of hsp70 and hsp90 during sequential steps in the process of glucocorticoid receptor.hsp90 heterocomplex assembly.
Kanelakis KC; Shewach DS; Pratt WB
J Biol Chem; 2002 Sep; 277(37):33698-703. PubMed ID: 12093808
[TBL] [Abstract][Full Text] [Related]
32. Solid-phase immunoassays in mechanism-based drug discovery: their application in the development of inhibitors of the molecular chaperone heat-shock protein 90.
Hardcastle A; Boxall K; Richards J; Tomlin P; Sharp S; Clarke P; Workman P; Aherne W
Assay Drug Dev Technol; 2005 Jun; 3(3):273-85. PubMed ID: 15971989
[TBL] [Abstract][Full Text] [Related]
33. A model for the cytoplasmic trafficking of signalling proteins involving the hsp90-binding immunophilins and p50cdc37.
Pratt WB; Silverstein AM; Galigniana MD
Cell Signal; 1999 Dec; 11(12):839-51. PubMed ID: 10659992
[TBL] [Abstract][Full Text] [Related]
34. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent.
Whitesell L; Sutphin PD; Pulcini EJ; Martinez JD; Cook PH
Mol Cell Biol; 1998 Mar; 18(3):1517-24. PubMed ID: 9488468
[TBL] [Abstract][Full Text] [Related]
35. Auditing the pharmacological accounts for Hsp90 molecular chaperone inhibitors: unfolding the relationship between pharmacokinetics and pharmacodynamics.
Workman P
Mol Cancer Ther; 2003 Feb; 2(2):131-8. PubMed ID: 12589030
[No Abstract] [Full Text] [Related]
36. Altered Hsp90 function in cancer: a unique therapeutic opportunity.
Bagatell R; Whitesell L
Mol Cancer Ther; 2004 Aug; 3(8):1021-30. PubMed ID: 15299085
[TBL] [Abstract][Full Text] [Related]
37. Blind cavefish and heat shock protein chaperones: a novel role for hsp90alpha in lens apoptosis.
Hooven TA; Yamamoto Y; Jeffery WR
Int J Dev Biol; 2004; 48(8-9):731-8. PubMed ID: 15558465
[TBL] [Abstract][Full Text] [Related]
38. Altered states: selectively drugging the Hsp90 cancer chaperone.
Workman P
Trends Mol Med; 2004 Feb; 10(2):47-51. PubMed ID: 15106614
[TBL] [Abstract][Full Text] [Related]
39. Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia.
Lauten M; Beger C; Gerdes K; Asgedom G; Kardinal C; Welte K; Schrappe M
Leukemia; 2003 Aug; 17(8):1551-6. PubMed ID: 12886242
[TBL] [Abstract][Full Text] [Related]
40. The molecular chaperones Hsp90 and Hsc70 are both necessary and sufficient to activate hormone binding by glucocorticoid receptor.
Rajapandi T; Greene LE; Eisenberg E
J Biol Chem; 2000 Jul; 275(29):22597-604. PubMed ID: 10781595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]